Canadian researchers decode Cannabis genome, find reason hemp differs from pot
TORONTO — It’s the same plant, but one type provides fibres for rope, while the other can make you high.
Now Canadian scientists, the first to sequence the genome of Cannabis sativa — the plant species that covers both hemp and marijuana — are beginning to understand why.
Page, who co-led the research project to decode the genetic underpinnings of the cannabis species, said the plant likely originated in Asia, around modern-day Afghanistan and surrounding area.
Archeological evidence shows hemp textiles were used in China at least 6,000 years ago and shamanistic material from a Chinese tomb dated about 2,700 years ago was likely from the marijuana-type plant, he said Wednesday from Saskatoon.
Page said people likely recognized the plant had several uses: it was the source of fibres to make rope and cloth, as well as seeds that produce oil and contain protein.
“But they also realized that the flowers of ... the female plant were full of a chemical that could relieve pain and cause a sort of pleasant intoxication,” he said. “So maybe what happened over time was those two uses — the medical and psychoactive — started to be separated from the rope and food use, and different types of strains were being grown for those uses.”
That suggests that early farmers may have been engaging in selective breeding even thousands of years ago.
Co-investigator Tim Hughes, a molecular biologist at the University of Toronto, sequenced the genomes of both Purple Kush, a marijuana strain widely used for medicinal purposes, and the Finola variety of hemp.
He then looked for differences to explain why marijuana produces THCA, or tetrahydrocannabinolic acid, the precursor of the active ingredient in marijuana, while hemp strains contain a non-psychoactive component.
Page said analysis showed that the THCA synthase gene, an essential enzyme in THCA production, “is turned on in marijuana, but switched off in hemp.”
The researchers, whose report is published Thursday in the journal Genome Biology, are making the cannabis genome publicly available for researchers worldwide.
Page said the data could help scientists better understand the plant’s properties and lead to expanded uses. For instance, because Cannabis sativa “puts on a huge amount of biomass each season ... there’s the idea that it could be used for producing biofuels in an efficient way.”
On the medical side, knowing the genetic makeup of cannabis could aid the development of drugs to treat pain, without the side-effects of straight marijuana, added Hughes.
“People want a painkiller, but they don’t necessarily want to be mentally incapacitated,” he said. “So if you could make variations in the molecule, that would increase the painkiller effect but decrease the effect on your mental capacity. For most people using it, that would probably be a step in the right direction.
“Although for others,” he said, laughing, “it might not matter.”